Vlastnictví managementu společnosti Amgen
Jaká je hodnota metriky Vlastnictví managementu společnosti Amgen?
Hodnota metriky Vlastnictví managementu společnosti Amgen, Inc. je 0.22%
Jaká je definice metriky Vlastnictví managementu?
Vlastnictví managementu (Insider Ownership) je poměr akcií vlastněných akcionáři v rámci firmy (akcionáři, kteří vlastní více než 5% společnosti nebo ve funkci ředitele či vedoucího odddělení) a veškerých vydaných akcií.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Vlastnictví managementu společností v sektoru Health Care sektor na XETRA ve srovnání se společností Amgen
Čemu se věnuje společnost Amgen?
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Firmy s metrikou vlastnictví managementu podobnou společnosti Amgen
- Hodnota metriky Vlastnictví managementu společnosti The Travelers Companies je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti NB Private Equity Partners je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti Weyerhaeuser Co je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti NB Private Equity Partners je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti CTI BioPharma Corp je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti Signify N.V je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti Amgen je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti Xilinx je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti Xilinx je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti Xilinx je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti Northrop Grumman je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti Fox Factory Corp je 0.22%
- Hodnota metriky Vlastnictví managementu společnosti CSX je 0.22%